Amphiregulin regulates odontogenic differentiation of dental pulp stem cells by activation of mitogen-activated protein kinase and the phosphatidylinositol 3-kinase signaling pathways

被引:14
|
作者
Li, Junqing [1 ,2 ,4 ]
Wang, Zhihua [1 ,2 ]
Wang, Juan [1 ,2 ]
Guo, Qian [1 ,2 ]
Fu, Yi [1 ,2 ,4 ]
Dai, Zihan [1 ,2 ]
Wang, Minghao [1 ,2 ]
Bai, Yu [1 ,2 ]
Liu, Xin [1 ,2 ]
Cooper, Paul R. [3 ]
Wu, Jiayuan [4 ]
He, Wenxi [5 ]
机构
[1] Fourth Mil Med Univ, State Key Lab Mil Stomatol, Xian 710032, Peoples R China
[2] Fourth Mil Med Univ, Natl Clin Res Ctr Oral Dis, Shaanxi Key Lab Stomatol, Dept Operat Dent & Endodont,Sch Stomatol, Xian 710032, Peoples R China
[3] Univ Otago, Fac Dent, Sir John Walsh Res Inst, Dept Oral Sci, POB 56, Dunedin 9054, New Zealand
[4] Zunyi Med Univ, Hosp Stomatol, 89 Wu Jiang Dong Rd, Zunyi 563003, Guizhou, Peoples R China
[5] Air Force Med Univ, Air Force Med Ctr, Dept Stomatol, 30 Fucheng Rd, Beijing 100142, Peoples R China
基金
中国国家自然科学基金;
关键词
Cell differentiation; Signal transduction; Tissue regeneration; GROWTH-FACTOR; CANCER CELLS; IN-VITRO; AUTOCRINE; KERATINOCYTE; LINE; EGF; REGENERATION; EXPRESSION; MIGRATION;
D O I
10.1186/s13287-022-02971-4
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Background Human dental pulp stem cells (hDPSCs) have received widespread attention in the fields of tissue engineering and regenerative medicine. Although amphiregulin (AREG) has been shown to play a vital function in the biological processes of various cell types, its effects on DPSCs remain largely unknown. The aim of this study was to explore the specific role of AREG as a biologically active factor in the regeneration of dental pulp tissue. Methods The growth of hDPSCs, together with their proliferation and apoptosis, in response to AREG was examined by CCK-8 assay and flow cytometry. We explored the effects of AREG on osteo/odontogenic differentiation in vitro and investigated the regeneration and mineralization of hDPSCs in response to AREG in vivo. The effects of AREG gain- and loss-of-function on DPSC differentiation were investigated following transfection using overexpression plasmids and shRNA, respectively. The involvement of the mitogen-activated protein kinase (MAPK) or phosphatidylinositol 3-kinase (PI3K)/Akt pathways in the mineralization process and the expression of odontoblastic marker proteins after AREG induction were investigated by using Alizarin Red S staining and Western blotting, respectively. Results AREG (0.01-0.1 mu g/mL) treatment of hDPSCs from 1 to 7 days increased hDPSCs growth and affected apoptosis minimally compared with negative controls. AREG exposure significantly promoted hDPSC differentiation, shown by increased mineralized nodule formation and the expression of odontoblastic marker protein expression. In vivo micro-CT imaging and quantitative analysis showed significantly greater formation of highly mineralized tissue in the 0.1 mu g/mL AREG exposure group in DPSC/NF-gelatin-scaffold composites. AREG also promoted extracellular matrix production, with collagen fiber, mineralized matrix, and calcium salt deposition on the composites, as shown by H&E, Masson, and Von Kossa staining. Furthermore, AREG overexpression boosted hDPSC differentiation while AREG silencing inhibited it. During the differentiation of hDPSCs, AREG treatment led to phosphorylation of extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and PI3K/Akt. Notably, a specific inhibitor of ERK, JNK, and PI3K/Akt signaling markedly reduced AREG-induced differentiation, as well as levels of phosphorylated ERK and JNK in hDPSCs. Conclusions The data indicated that AREG promoted odontoblastic differentiation and facilitated regeneration and mineralization processes in hDPSCs.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Simultaneous inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways augment the sensitivity to actinomycin D in Ewing sarcoma
    Takatoshi Yamamoto
    Takatoshi Ohno
    Kazuhiko Wakahara
    Akihito Nagano
    Gou Kawai
    Mitsuru Saitou
    Iori Takigami
    Aya Matsuhashi
    Kazunari Yamada
    Katsuji Shimizu
    Journal of Cancer Research and Clinical Oncology, 2009, 135 : 1125 - 1136
  • [22] Inhibition of human cardiac fibroblast mitogenesis by blockade of mitogen-activated protein kinase and phosphatidylinositol 3-kinase
    Hafizi, S
    Chester, AH
    Yacoub, MH
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1999, 26 (07) : 511 - 513
  • [23] Phosphatidylinositol 3-kinase and Ras/mitogen-activated protein kinase signaling pathways are required for the regulation of 5-aminolevulinate synthase gene expression by insulin
    Scassa, ME
    Guberman, AS
    Varone, CL
    Cánepa, ET
    EXPERIMENTAL CELL RESEARCH, 2001, 271 (02) : 201 - 213
  • [24] Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cells
    Serova, Maria
    Ghoul, Aida
    Benhadji, Karim A.
    Faivre, Sandrine
    Le Tourneau, Christophe
    Cvitkovic, Esteban
    Lokiec, Francois
    Lord, Janet
    Ogbourne, Steven M.
    Calvo, Fabien
    Raymond, Eric
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (04) : 915 - 922
  • [25] Genetic Alterations in the Ras/Raf/Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase/Akt Signaling Pathways in the Follicular Variant of Papillary Thyroid Carcinoma
    Santarpia, Libero
    Myers, Jeffrey N.
    Sherman, Steven I.
    Trimarchi, Francesco
    Clayman, Gary L.
    El-Naggar, Adel K.
    CANCER, 2010, 116 (12) : 2974 - 2983
  • [26] Phosphatidylinositol 3-kinase is an early intermediate in the G beta gamma-mediated mitogen-activated protein kinase signaling pathway
    Hawes, BE
    Luttrell, LM
    vanBiesen, T
    Lefkowitz, RJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) : 12133 - 12136
  • [27] Activation mitogen-activated protein (MAP) kinase by PDGF-BB is mediated by phosphatidylinositol 3-kinase in normal human osteoblastic cells.
    Chaudhary, LR
    Avioli, LV
    FASEB JOURNAL, 1997, 11 (09): : A1175 - A1175
  • [28] A novel pathway of ceramide signaling through tyrosine kinase, p21ras, phosphatidylinositol 3-kinase and mitogen-activated protein kinase
    Brindley, DN
    Kikuchi, Y
    Chan, E
    Stone, JC
    Hanna, AN
    FASEB JOURNAL, 1998, 12 (08): : A1289 - A1289
  • [29] Midkine inhibits caspase dependent apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase in cultured neurons
    Owada, K
    Sanjo, N
    Kobayashi, T
    Mizusawa, H
    Muramatsu, H
    Muramatsu, T
    Michikawa, M
    JOURNAL OF NEUROCHEMISTRY, 1999, 73 (05) : 2084 - 2092
  • [30] Comparison of the roles of mitogen-activated protein kinase kinase and phosphatidylinositol 3-kinase signal transduction in neutrophil effector function
    Coffer, PJ
    Geijsen, N
    M'Rabet, L
    Schweizer, RC
    Maikoe, T
    Raaijmakers, JAM
    Lammers, JWJ
    Koenderman, L
    BIOCHEMICAL JOURNAL, 1998, 329 : 121 - 130